Pieris (PIRS): Quarterly Revenue Growth

Corporate company logo of Pieris Pharmaceuticals, Inc. (PIRS)

A steady inflow of capital from giant partners via the Anticalin platform ensures R&D expenditure coverage, which is confirmed by the quarterly percentage growth in revenue for Pieris Pharmaceuticals (PIRS). The 0.00 level captures the current state of this metric's dynamics. However, sanctions and logistics disruptions complicate global protein testing, while portfolio restructuring necessitates new strategic alliances for expansion into the oncology sphere.

PIRS Pieris Pharmaceuticals Inc Quarterly Revenue Increase (07/04/2022 - 11/20/2026)

Metric breakdowns and analytics for Pieris (PIRS)

- stock price and consensus target price:
- cash and cash flow metrics:
General company analysis:PIRS - Pieris
Mass-produced product of Pieris Pharmaceuticals Inc

The dynamics of this indicator measure the percentage change in operating revenues between the current and previous quarters, allowing investors to assess the pace of business scaling. For Pieris Pharmaceuticals (PIRS), which utilizes protein production outsourcing in the US, the quarterly revenue growth rate serves as a marker for the efficiency of its flexible, low-CAPEX model, reflecting real market demand for its developments.

Key competitors

HLN - Revenue Growth QoQ|Quarterly Revenue Growth Rate kenvue.com|Verona Pharma (VRNA) - Revenue Growth QoQ|Quarterly Revenue Growth Rate Jyong Biotech Limited (MENS)|LGND (Ligand Pharmaceuticals Incorporated) - Quarterly Revenue Growth|Quarterly Revenue Growth Rate Amneal Pharmaceuticals Inc AMRX|Quarterly Revenue Growth PRGO|Sales Change QoQ ALVO|Quarterly Revenue Growth LQDA (Liquidia Technologies)|Quarterly Revenue Growth Galapagos GLPG|ANI Pharmaceuticals Inc - Quarterly Revenue Growth|MNKD (MannKind Corp.) - Sales Growth QoQ|AMPH: Quarterly Revenue Growth|PCRX (Pacira BioSciences) - Revenue Growth QoQ|Revenue Growth QoQ ARS Pharmaceuticals Inc|Quarterly Sales Growth Theravance Biopharma, Inc. (TBPH)|Quarterly Sales Growth AQST (Aquestive Pharma)|SCPH - Quarterly Revenue Growth Rate|Quarterly Revenue Growth TECX (Tectonic Therapeutic, Inc.)|TNXP - Quarterly Sales Growth|China SXT Pharmaceuticals, Inc. - Quarterly Revenue Growth|EPRX - Quarterly Revenue Growth|BHST: Quarterly Revenue Growth|Quarterly Revenue Growth Rate eXoZymes Inc (EXOZ)|ORMP (oramed.com) - Quarterly Revenue Growth|Sales Growth QoQ ENTX (Entera Bio)|Revenue Growth QoQ MindWalk (HYFT)|Quarterly Revenue Growth ABVC BioPharma, Inc. (ABVC)|Revenue Growth QoQ Cumberland Corp CPIX|QNTM - Quarterly Sales Growth|FGEN - Revenue Growth QoQ|TELO - Quarterly Revenue Growth|Rani Therapeutics Inc (RANI) - Revenue Growth QoQ|Sales Growth QoQ SNYR|Revenue Growth QoQ Rallybio Corp|Revenue Growth QoQ LEXX|Quarterly Revenue Growth PULM|PTHL: Revenue Dynamics QoQ|Quarterly Revenue Growth APM (Aptorum Group Ltd)|LYRA - Quarterly Sales Growth|Impact BioMedical Inc - Quarterly Revenue Growth|Revenue Dynamics QoQ TNFA|YCBD (cbdmd.com) - Quarterly Sales Growth|painreform.com - Quarterly Revenue Increase|Quarterly Sales Growth CYTO|Revenue Growth QoQ LIPO|Revenue Growth QoQ optinose.com (OPTN)|Quarterly Revenue Growth Procaps Group Corp (PROC)|Quarterly Revenue Growth PTPI (petrospharma.com)|Quarterly Revenue Increase QLI|ACELYRIN - Quarterly Revenue Growth|Quarterly Revenue Increase TFFP (TFF Pharmaceuticals Inc.)